MedTrace Logo

A Study Testing Safety and Tolerance of the ReWalk Exoskeleton Suit

NCT00627107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2010-11-30

No results posted yet for this study

Summary

The ReWalk enables people with lower limb disabilities to carry out routine ambulatory functions (stand, walk, climb stairs etc.). It can be used by people with disabilities such as spinal cord injury, brain injury, stroke, multiple sclerosis, cerebral palsy and other severe walking impairments. The device promises to restore the dignity of disabled persons, enabling them to work and improve their general health and quality of life, as well as significantly reduce medical and other related expenses.

Conditions

  • Paraplegia
  • SCI

Interventions

DEVICE

ReWalk - a motorized exoskeleton suit

The subject will wear the ReWalk suit and have training sessions for walking with the device.

Sponsors & Collaborators

  • ReWalk Robotics, Inc.

    lead INDUSTRY

Principal Investigators

  • Gabi Zeilig, MD · Sheba Medical Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00627107 on ClinicalTrials.gov